283 related articles for article (PubMed ID: 16797904)
1. A comparison of elderly and adult multiple organ dysfunction syndrome in the rat model.
Zhu Q; Qian X; Wang S; Yin T; Yang J; Xue Q; Xu B
Exp Gerontol; 2006 Aug; 41(8):771-7. PubMed ID: 16797904
[TBL] [Abstract][Full Text] [Related]
2. Altered chemokine response in an animal model of multiple organ dysfunction syndrome induced by zymosan.
Thomas NJ; Umstead TM; Phelps DS
J Pediatr Surg; 2005 Mar; 40(3):464-9. PubMed ID: 15793719
[TBL] [Abstract][Full Text] [Related]
3. [Apoptosis of pulmonary alveolar macrophages in aged and adult rats: a comparative study].
Qian XS; Zhu QL; Yang J; Yin T; Wang SW
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):253-6. PubMed ID: 15854487
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice.
Jansen MJ; Hendriks T; de Man BM; van der Meer JW; Goris RJ
Cytokine; 1999 Sep; 11(9):713-21. PubMed ID: 10479408
[TBL] [Abstract][Full Text] [Related]
5. Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin.
Shayevitz JR; Miller C; Johnson KJ; Rodriguez JL
Shock; 1995 Dec; 4(6):389-96. PubMed ID: 8608394
[TBL] [Abstract][Full Text] [Related]
6. Role of the lung in the progression of multiple organ dysfunction syndrome in ageing rat model.
Wang XP; Zhu QL; Xue Q; Li Y; Qian XS; Wang ZL; Wang SW
Chin Med J (Engl); 2012 Aug; 125(15):2708-13. PubMed ID: 22931979
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS).
Ferrer TJ; Webb JW; Wallace BH; Bridges CD; Palmer HE; Robertson RD; Cone JB
J Surg Res; 1998 Jul; 77(2):157-64. PubMed ID: 9733603
[TBL] [Abstract][Full Text] [Related]
8. [Effects of antithrombin-III on cytokines in rats with multiple organ dysfunction syndrome].
Ren XS; Qiao YJ; Xia XH; Xu J; Jia HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):565-7. PubMed ID: 16146608
[TBL] [Abstract][Full Text] [Related]
9. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Caminiti R; Esposito E; Di Bella P; Cuzzocrea S
Shock; 2008 May; 29(5):560-71. PubMed ID: 17724436
[TBL] [Abstract][Full Text] [Related]
10. [A model of multiple organ injury induced by Klebsiella pneumoniae pneumonia in aged rats].
Li JS; Wang SF; Qin JL; Zhang HJ; Li SY; Yu HB; Wang F; Liu SH; Li Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Apr; 21(4):226-9. PubMed ID: 19374791
[TBL] [Abstract][Full Text] [Related]
11. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Malleo G; Mazzon E; Genovese T; Di Paola R; Caminiti R; Esposito E; Bramanti P; Cuzzocrea S
Cytokine; 2008 Feb; 41(2):136-43. PubMed ID: 18160304
[TBL] [Abstract][Full Text] [Related]
12. [Change in gene expression of inflammation-related genes induced in multiple organ dysfunction syndrome induced by infection of injuries in rat].
Ban Y; Shen H; Li TS
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):146-9. PubMed ID: 17376266
[TBL] [Abstract][Full Text] [Related]
13. [An experimental study of a rat model with MODS as a result of trauma induced infection].
Ban Y; Shen H; Li TS
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jan; 20(1):41-4. PubMed ID: 18199401
[TBL] [Abstract][Full Text] [Related]
14. The effects of L-NG-nitroarginine in a zymosan-induced multiple organ dysfunction syndrome model.
Ozel H; Yuksel BC; Berkem H; Avsar FM; Guler G; Iskit AB; Guc MO; Hengirmen S
Eur Surg Res; 2009; 43(2):211-8. PubMed ID: 19556797
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome.
Jansen MJ; Hendriks T; Hermsen R; Van der Meer JW; Goris RJ
Cytokine; 1998 Nov; 10(11):904-10. PubMed ID: 9878128
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin-induced acute lung injury and organ dysfunction are attenuated by pentobarbital anaesthesia.
Kao SJ; Su CF; Liu DD; Chen HI
Clin Exp Pharmacol Physiol; 2007; 34(5-6):480-7. PubMed ID: 17439419
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
Dugo L; Chatterjee PK; Mazzon E; McDonald MC; Paola RD; Fulia F; Caputi AP; Thiemermann C; Cuzzocrea S
Intensive Care Med; 2002 Jun; 28(6):775-88. PubMed ID: 12107686
[TBL] [Abstract][Full Text] [Related]
18. Generation of pro-inflammatory and anti-inflammatory cytokines in the gut in zymosan-induced peritonitis.
Sakashita Y; Hiyama E; Imamura Y; Murakami Y; Sugahara Y; Takesue Y; Matsuura Y; Yokoyama T
Hiroshima J Med Sci; 2000 Mar; 49(1):43-8. PubMed ID: 10824456
[TBL] [Abstract][Full Text] [Related]
19. [Value of monitoring oxygen metabolism in multiple organ dysfunction syndrome after severe trauma].
Tian LH; Gao W; Hu D; Zhao H; Yi CL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):21-4. PubMed ID: 17207359
[TBL] [Abstract][Full Text] [Related]
20. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome.
Wang H; Ma S
Am J Emerg Med; 2008 Jul; 26(6):711-5. PubMed ID: 18606328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
